Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026)

Fortrea Holdings (FTRE) reported Operating Expenses of $639.9 million for Q1 2026, down 45.37% on a YoY basis from $1.2 billion in Q1 2025, and down 5.07% quarter-over-quarter from $674.1 million in Q4 2025.

Fortrea Holdings (FTRE) Operating Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Operating Expenses for 5 years, with the latest figure at $639.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses fell 45.37% year-over-year to $639.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 billion (down 7.98% YoY), and the FY2025 full-year result was $3.6 billion, up 25.81% from the prior year.
  • Operating Expenses for Q1 2026 stood at $639.9 million, down from $674.1 million in the prior quarter.
  • The five-year high for Operating Expenses was $1.2 billion in Q1 2025, with the low at $488.3 million in Q4 2022.
  • Historically, Operating Expenses has averaged $738.0 million across 5 years, with a median of $701.5 million in 2023.
  • Annual changes were most pronounced in 2025 — Operating Expenses jumped 67.46% — and 2026, when it slumped 45.37%.
  • Fortrea Holdings' Operating Expenses stood at $488.3 million in 2022, then soared by 50.26% to $733.7 million in 2023, then rose by 2.58% to $752.6 million in 2024, then decreased by 10.43% to $674.1 million in 2025, then dropped by 5.07% to $639.9 million in 2026.
  • The last three Operating Expenses figures came in at $639.9 million (Q1 2026), $674.1 million (Q4 2025), and $709.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.33 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -138.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 574,669.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.85 Bn
9 Abivax 91.96 Bn 91.96 Bn - -67.40 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 639.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 639.90 Mn
Dec 31, 2025 674.10 Mn
Sep 30, 2025 709.90 Mn
Jun 30, 2025 1.04 Bn
Mar 31, 2025 1.17 Bn
Dec 31, 2024 752.60 Mn
Sep 30, 2024 692.90 Mn
Jun 30, 2024 713.30 Mn
Mar 31, 2024 699.50 Mn
Dec 31, 2023 733.70 Mn
Sep 30, 2023 703.50 Mn
Jun 30, 2023 693.50 Mn
Mar 31, 2023 679.80 Mn
Dec 31, 2022 488.30 Mn
Sep 30, 2022 693.40 Mn
Jun 30, 2022 721.90 Mn